Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology,General Medicine
Reference8 articles.
1. ABN Guidance on the Use of Disease-Modifying Therapies in Multiple Sclerosis in Response to the Threat of a Coronavirus Epidemic [WWW Document],2020
2. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis;Hauser;N. Engl. J. Med.,2017
3. Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: results from the phase 3 randomized opera I, opera II, and oratorio studies;Mayer;Mult. Scler. Relat. Disord.,2019
4. Ocrelizumab versus placebo in primary progressive multiple sclerosis;Montalban;N. Engl. J. Med.,2017
5. Fulminant hepatitis associated with echovirus 25 during treatment with ocrelizumab for multiple sclerosis;Nicolini;JAMA Neurol.,2019
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience;Current Neuropharmacology;2024-02
2. A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder;Current Neurology and Neuroscience Reports;2023-08-04
3. Therapeutics for the Management of Cytokine Release Syndrome in COVID-19;Current Topics in Medicinal Chemistry;2023-01
4. Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis;Journal of Clinical Neurology;2023
5. Risk and prognostic factors for SARS-CoV-2 infection in Spanish population with multiple sclerosis during the first five waves;Frontiers in Neurology;2022-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3